Gabriele Di Luozzo, MD Email Gabriele Di Luozzo
- ASSOCIATE PROFESSOR | Cardiovascular Surgery
- Cardiovascular Surgery
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
Book an Appointment - Gabriele Di Luozzo, MD
Gabriele Di Luozzo, MD, is an Associate Professor in the Department of Cardiovascular Surgery at the Mount Sinai Health Care System. He currently is the Director of Thoracic Aortic Surgery at the Mount Sinai St. Luke’s and Beth Israel Campuses. He directs one of the largest Thoracic Aortic Programs in the country with over 1,400 patients maintained in his aortic aneurysm surveillance program.
Dr. Di Luozzo is originally from New York City and has gained his training in Cardiac and Aortic Surgery in the New England area. He has returned to his roots in New York City and has been in practice for over 11 years. He has been on faculty at Mount Sinai Hospital for the majority of his time as a practicing cardiac surgeon. One of the main reasons Dr. Di Luozzo returned to New York was to work alongside Dr. Randall Griepp, a pioneer cardiac and aortic surgeon at Mount Sinai Hospital. After completing his aortic surgery fellowship, he joined Dr. Griepp as his associate until he retired in 2012.
As a cardiac surgeon he has focused his practice on patients with valvular heart disease (like bicuspid aortic valve), aortic and connective tissue disorders (like Marfan and Loey-Dietz Disorder) and aortic dissections. He approaches most patients with valvular heart disease with a minimally invasive approach to reduce pain, blood loss and promote a more speedy recovery. With respect to aortic conditions, he specializes in all areas of the aorta from the aortic valve to the aortic bifurcation. He has a busy practice in aortic root (David procedure) replacement surgery, aortic arch and thoracoabdominal aortic aneurysm repairs. He is one the busiest surgeons in the north east and south east regions with patients requiring an aortic arch and thoracoabdominal aortic aneurysm repair. Each patient is evaluated for either an endovascular (TEVAR) or open repair depending on patient’s needs, condition, and appropriateness of either approach.
He has authored just fewer than 100 publications mostly in the area of thoracic aortic diseases and outcomes from different operations. His research has been presented at both national and international scientific meetings. Dr. Di Luozzo is the Director of a large animal laboratory which investigates ways to prevent neurologic injuries after different aortic procedures. This is a unique laboratory since much of protective measures used in the operating room world-wide have been first investigated in this laboratory.
- Abdominal Aortic Aneurysm Repair
- Aortic Aneurysm
- Aortic Aneurysm Repair/Removal
- Aortic Coarctation
- Aortic Dissection
- Aortic Insufficiency
- Aortic Regurgitation
- Aortic Stenosis
- Aortic Stenosis - Adult
- Aortic Valve Disease
- Aortic Valve Replacement
- Atrial Fibrillation
- Bacterial Endocarditis
- Bypass Surgery Consultation - CABG
- Cardiac Catheterization
- Cardiac Tamponade
- Cardiothoracic Surgery Consultation
- Coronary Artery Disease
- Heart Murmur
- Heart Valve Replacement
- Leaky Heart Valve
- Marfan Syndrome
- Minimally Invasive Bypass Consultation - OPCAB
- Mitral Stenosis
- Mitral Valve Disease
- Pericardial Cyst / Mass
- Pleural Effusion
- Pulmonary Valve Disease
- Thoracic Aortic Aneurysm
- Traumatic Aortic Disruption
MD, Ross University
Yale-New Haven Hospital
Residency, General Surgery
St. Mary's Hospital
Residency, General Surgery
Beth Israel Deaconess Medical Center- Harvard Medical School
Residency, Cardiothoracic Surgery
University of Miami Hospital
Fellowship, Thoracic Surgery
Mount Sinai Hospital
Italian, Spanish, English
Best Abstract Presentation
6th International Redo Cardiac Surgery in Adults Symposium San Francisco, CA
Resident Teaching Award
Beth Israel Deaconess Medical Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Di Luozzo did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.